By Drug Target Review2025-06-10T09:00:02
Nearly a billion people are affected by chronic organ scarring, yet treatments remain limited. Now, Duke-NUS researchers have compiled a scientific ‘handbook’ of immune cell insights that could fast-track breakthroughs in fibrosis therapy.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
2023-02-07T15:25:20
Sponsored by Bio-Techne
2023-07-03T10:28:23
Sponsored by Merck
Site powered by Webvision Cloud